Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing

Monoclonal antibodies have been approved by the Food and Drug Administration for the treatment of various human cancers. More recently, oligonucleotide aptamers have risen increasing attention for cancer therapy thanks to their low size (efficient tumor penetration) and lack of immunogenicity, even...

Descripción completa

Detalles Bibliográficos
Autores principales: Passariello, Margherita, Camorani, Simona, Vetrei, Cinzia, Cerchia, Laura, De Lorenzo, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770524/
https://www.ncbi.nlm.nih.gov/pubmed/31470510
http://dx.doi.org/10.3390/cancers11091268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770524/
https://www.ncbi.nlm.nih.gov/pubmed/31470510
http://dx.doi.org/10.3390/cancers11091268

Ejemplares similares